Exploring the Cytokine Therapeutics Landscape: Where Are We Now?

Time: 8:30 am
day: Conference Day One

Details:

  • Overview of the oncology and non-oncology cytokine-based drug development landscape, both preclinical and clinical
  • Analyzing and evaluating companies exiting the field or dropping cytokine pipelines
  • Outlining novel cytokine engineering strategies

Speakers: